Literature DB >> 26432889

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.

Aiko Sato-Otsubo1, Yasuhito Nannya2, Koichi Kashiwase3, Makoto Onizuka4, Fumihiro Azuma3, Yoshiki Akatsuka5, Yasuko Ogino6, Masahiro Satake3, Masashi Sanada1, Shigeru Chiba7, Hiroh Saji8, Hidetoshi Inoko4, Giulia C Kennedy9, Ken Yamamoto10, Satoko Morishima11, Yasuo Morishima12, Yoshihisa Kodera13, Takehiko Sasazuki14, Seishi Ogawa1.   

Abstract

Acute graft-versus-host disease (aGVHD) represents one of the major complications in allogeneic stem cell transplantation and is primarily caused by genetic disparity between the donor and recipient. In HLA-matched transplants, the disparity is thought to be determined by loci encoding minor histocompatibility antigens (minor H antigens), which are presented by specific HLA molecules. We performed a genome-wide association study (GWAS) to identify minor H antigen loci associated with aGVHD. A total of 500 568 single nucleotide polymorphisms (SNPs) were genotyped for donors and recipients from 1589 unrelated bone marrow transplants matched for HLA-A, -B, -C, -DRB1, and -DQB1, followed by the imputation of unobserved SNPs. We interrogated SNPs whose disparity between the donor and recipient was significantly associated with aGVHD development. Without assuming HLA unrestriction, we successfully captured a known association between HLA-DPB1 disparity (P = 4.50 × 10(-9)) and grade II-IV aGVHD development, providing proof of concept for the GWAS design aimed at discovering genetic disparity associated with aGVHD. In HLA-restricted analyses, whereby association tests were confined to major subgroups sharing common HLA alleles to identify putative minor H antigen loci, we identified 3 novel loci significantly associated with grade III-IV aGVHD. Among these, rs17473423 (P = 1.20 × 10(-11)) at 12p12.1 within the KRAS locus showed the most significant association in the subgroup, sharing HLA-DQB1*06:01. Our result suggested that a GWAS can be successfully applied to identify allele mismatch associated with aGVHD development, contributing to the understanding of the genetic basis of aGVHD.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26432889     DOI: 10.1182/blood-2015-03-630707

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.

Authors:  Yoshihiro Inamoto; Jennifer White; Reiko Ito; Paul J Martin; Giancarlo Fatobene; Ayumu Ito; Takashi Tanaka; Saiko Kurosawa; Sung-Won Kim; Merav Bar; Mohamed L Sorror; Brenda M Sandmaier; Stephanie J Lee; Takahiro Fukuda; Mary E D Flowers
Journal:  Blood Adv       Date:  2019-09-24

Review 2.  Transplant genetics and genomics.

Authors:  Joshua Y C Yang; Minnie M Sarwal
Journal:  Nat Rev Genet       Date:  2017-03-13       Impact factor: 53.242

3.  Patient HLA Germline Variation and Transplant Survivorship.

Authors:  Effie W Petersdorf; Philip Stevenson; Mari Malkki; Roland K Strong; Stephen R Spellman; Michael D Haagenson; Mary M Horowitz; Ted Gooley; Tao Wang
Journal:  J Clin Oncol       Date:  2018-06-14       Impact factor: 44.544

4.  Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.

Authors:  Satoko Morishima; Takashi Shiina; Shingo Suzuki; Seishi Ogawa; Aiko Sato-Otsubo; Koichi Kashiwase; Fumihiro Azuma; Toshio Yabe; Masahiro Satake; Shunichi Kato; Yoshihisa Kodera; Takehiko Sasazuki; Yasuo Morishima
Journal:  Blood       Date:  2017-12-15       Impact factor: 22.113

Review 5.  Genetic background and transplantation outcomes: insights from genome-wide association studies.

Authors:  Francesca Zanoni; Krzysztof Kiryluk
Journal:  Curr Opin Organ Transplant       Date:  2020-02       Impact factor: 2.269

6.  Toll-like receptor genetic variations in bone marrow transplantation.

Authors:  Kaori Uchino; Shohei Mizuno; Aiko Sato-Otsubo; Yasuhito Nannya; Motonori Mizutani; Tomohiro Horio; Ichiro Hanamura; J Luis Espinoza; Makoto Onizuka; Koichi Kashiwase; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Noriko Doki; Koichi Miyamura; Takehiko Mori; Seishi Ogawa; Akiyoshi Takami
Journal:  Oncotarget       Date:  2017-07-11

Review 7.  Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  F1000Res       Date:  2017-05-03

Review 8.  Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Authors:  Rihab Gam; Pranali Shah; Rachel E Crossland; Jean Norden; Anne M Dickinson; Ralf Dressel
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

Review 9.  Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.

Authors:  Ruxiu Tie; Tiansong Zhang; Bo Yang; Huarui Fu; Biqing Han; Jian Yu; Yamin Tan; He Huang
Journal:  Oncotarget       Date:  2017-04-18

10.  Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease.

Authors:  Kati Hyvärinen; Jarmo Ritari; Satu Koskela; Riitta Niittyvuopio; Anne Nihtinen; Liisa Volin; David Gallardo; Jukka Partanen
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.